000 01016 a2200277 4500
005 20250518091742.0
264 0 _c20210202
008 202102s 0 0 eng d
022 _a1365-2710
024 7 _a10.1111/jcpt.13127
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShah, Rashmi R
245 0 0 _aGenotype-guided warfarin therapy: Still of only questionable value two decades on.
_h[electronic resource]
260 _bJournal of clinical pharmacy and therapeutics
_cJun 2020
300 _a547-560 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
650 0 4 _aPharmacogenetics
650 0 4 _aThromboembolism
_xdrug therapy
650 0 4 _aWarfarin
_xtherapeutic use
773 0 _tJournal of clinical pharmacy and therapeutics
_gvol. 45
_gno. 3
_gp. 547-560
856 4 0 _uhttps://doi.org/10.1111/jcpt.13127
_zAvailable from publisher's website
999 _c30738656
_d30738656